Stock Analysis of Aptinyx Inc (APTX) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code APTX
Close 0.096
Change 0.0029 / 3.11 %
Volume 231126
Vol Change 201919 / 691.34 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bullish
Growth Index Low Growth Stock
Value Index Mild Value
Profitability Index Poor Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of Aptinyx Inc
PE (TTM)

-0.098

Very Poor
Price / Book

0.133

Excellent
Price / Sales

0

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

6500.71 K

Enterprise Value

-24801.29 K

ROA (TTM)

-84.77

Very Poor
ROE (TTM)

-134.92

Very Poor
Net Margin (TTM)

0

Poor
Revenue

100.00 %

0
Net Profit

13.40 %

-64849.00 K
Debt to Equity

0.650

Good
Altman Z Score

-9.33

Very Poor
Quick Ratio

0

Poor
Cash Ratio

8.93

Excellent


Highs/Lows of Aptinyx Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.095 1.05 % 1.66 % 0.0960.086529-Dec-2327-Dec-23
Two Week0.063 52.38 % 2.46 % 0.0960.05529-Dec-2322-Dec-23
One Month0.0635 51.18 % 6.86 % 0.0960.05529-Dec-2322-Dec-23
Three Month0.0674 42.43 % 6.69 % 0.0960.03129-Dec-2303-Nov-23
Six Months0.0799 20.15 % 16.73 % 0.0960.03129-Dec-2303-Nov-23
One year0.3 68.00 % 26.63 % 0.720.03113-Feb-2303-Nov-23
Two year2.72 96.47 % 36.06 % 0.750.03116-May-2203-Nov-23
Five year16.61 99.42 % 86.89 % 0.720.00913-Feb-2319-Dec-23


Technical View of Aptinyx Inc
RSI

66.31

Neutral
MACD

0.0080

Bullish
ADX

19.33

Bearish
Super Trend

0.073

Mild Bullish
Williams %R

0

Mild Bearish
CCI

115.03

Bearish


EMA 5

0.092

Strong Bullish
EMA 15

0.082

Bullish
EMA 50

0.072

Strong Bullish
EMA 100

0.077

Strong Bullish
SMA 100

0.068

Bullish
SMA 200

0.082

Whipsaw
SMA 5 / 20

0.093 / 0.074

Strong Bullish
SMA 15 / 50

0.078 / 0.068

Strong Bullish
SMA 50 / 200

0.068 / 0.082

Mild Bearish




Charts of Aptinyx Inc


Returns of Aptinyx Inc with Peers
Period / StockAPTXSONXVVOSHEPA
1 Week1.05%6.10%11.44%-3.31%
1 Mth51.18%4.13%-17.65%-41.79%
3 Mth42.43%-37.20%-56.34%-52.82%
6mth20.15%-60.19%-47.66%-62.86%
1 Year-68.00%-92.22%-72.95%-86.81%
2 Year-96.47%-96.74%-93.69%-92.16%
5 Years-99.42%---99.29%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Aptinyx Inc with Peers
Ratio / StockAPTXSONXVVOSHEPA
PE-0.098-42.95-125.55-0.107
P/B0.13352.90968.650.233
ROA-84.77-57.95-122.79-147.92
ROE-134.92-123.17-771.50-218.45
Debt To Equity0.6500.4391.150.0159
Revenue0
100.00 % 		44403.00 K
6.59 % 		14503.00 K
9.49 % 		0
%
Net Income-64849.00 K
13.40 % 		-60893.00 K
6.74 % 		-15413.00 K
35.36 % 		-44677.89 K
5.87 %


Technicals of Aptinyx Inc with Peers
Technical / StockAPTXSONXVVOSHEPA-
ADX19.339.8832.1423.45
CMF0.502-0.0205-0.0143-0.147
MFI71.2580.2539.3847.70
RSI66.3149.0939.2634.82
MACD Abv SignalTrueTrueTrueTrue
Price Above 50 MATrueFalseFalseFalse-
Price Above 200 MATrueFalseFalseFalse-


About : Aptinyx Inc

Address : 909 Davis Street, Evanston, IL, United States, 60201
Tel : 847 871 0377
URL : https://www.aptinyx.com
Code : APTX, ISIN : US03836N1037, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 21_Jun_2018
Employee Count : 12

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Its lead product candidate NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat opioid use disorder, or OUD; and in preclinical trial for the treatment of alcohol use disorder, or AUD. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.


Note : All Data Generated at the End of Trading Hours (EOD Data)